We provide you with 20 years of free, institutional-grade data for SPRB stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of SPRB. Explore the full financial landscape of SPRB stock.
| Reported Date | CIK | Ticker | Type |
|---|
Spruce Biosciences, Inc(NASDAQ:SPRB) 
Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for patients suffering from cong...
Website: http://www.sprucebiosciences.com
Founded: 2014
Full Time Employees: 15
CEO: Richard A. King
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report about SPRB stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.